-
Mashup Score: 65Virtual Grand Rounds in Radiation Oncology - 2 month(s) ago
Latest Science – Top Speakers – Interactive Format We proudly present the newly established “Virtual Grand Rounds in Radiation Oncology”.
Source: www.usz.chCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 47Proton radiotherapy significantly reduces pneumonia in oesophageal cancer patients. - 2 month(s) ago
Neoadjuvant chemoradiotherapy (nCRT) followed by surgical resection is the current standard of care for oesophageal cancer (EC) patients. This treatment is associated with a variety of complications, with pneumonia being the most common. We hypothesize that proton radiotherapy (PRT) can significantly reduce the incidence of pneumonia compared to photon radiotherapy (PhRT).
Source: www.redjournal.orgCategories: General Medicine News, Oncologists1Tweet-
Influence of Proton vs Photon RT on risk of pneumonia in oesophageal ca pts - incidence lower after PRT vs PhRT 12% vs 32% principal component analysis - mean dose heart & lungs - distribution of dose btw lungs & heart - vol receiving ≤20Gy https://t.co/siSgZnO2Pw
-
-
Mashup Score: 64Dissemination and Implementation – A Primer for Accelerating “Time to Translation” in Radiation Oncology - 2 month(s) ago
The field of radiation oncology has achieved significant technological and scientific advancements in the 21st century. Yet uptake of new evidence-based practices has been heterogeneous, even in the presence of national and international guidelines. Addressing barriers to practice change requires a deliberate focus on developing and testing strategies tailored to improving care delivery and quality, especially for vulnerable patient populations. Implementation science provides a systematic approach to developing and testing strategies, though applications in radiation oncology remain limited.
Source: www.redjournal.orgCategories: General Medicine News, Oncologists1Tweet-
Radiation Oncology is characterized by rapid innovation Dissemination & implementation are important aspects to bring this progress to our cancer patients in daily practice Well written review by @ErinGillespieMD and colleagues 👇 https://t.co/iFVarskbWD
-
-
Mashup Score: 52Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study - 2 month(s) ago
The value of stereotactic body radiotherapy (SBRT) in patients with oligometastatic head-and-neck squamous cell carcinoma (HNSCC) remains unclear, as existing evidence is primarily derived from retrospective single-center analyses with small patient cohorts. This study aimed to evaluate the outcomes of pulmonary SBRT in patients with oligometastatic HNSCC and to identify factors associated with survival.
Source: www.redjournal.orgCategories: General Medicine News, Oncologists1Tweet-
Retrospective multicenter study of SBRT for pulmonary oligometastatic HNSCC - 16 centers, 178 pts, 284 pulmonary mets - 1a local failure rate 5.5% - no grade 4/5 toxicities 👉 supporting prospective evaluation, in preparation by @EORTC & P Balermpas https://t.co/Cxg0mXLAmi
-
-
Mashup Score: 66Virtual Grand Rounds in Radiation Oncology - 2 month(s) ago
Latest Science – Top Speakers – Interactive Format We proudly present the newly established “Virtual Grand Rounds in Radiation Oncology”.
Source: www.usz.chCategories: General Medicine News, Oncologists2Tweet-
‼️ TOMORROW - the very first ‼️ Virtual Grand Rounds in Radiation Oncology https://t.co/fIgYIx5hy7 17:00 - 17.30 CEST - Zoom link on Meeting homepage Prof. Nicholas van As PACE trials and SBRT for prostate cancer
-
-
Mashup Score: 66Virtual Grand Rounds in Radiation Oncology - 3 month(s) ago
Latest Science – Top Speakers – Interactive Format We proudly present the newly established “Virtual Grand Rounds in Radiation Oncology”.
Source: www.usz.chCategories: General Medicine News, Oncologists2Tweet-
‼️ TOMORROW - the very first ‼️ Virtual Grand Rounds in Radiation Oncology https://t.co/fIgYIx5hy7 17:00 - 17.30 CEST - Zoom link on Meeting homepage Prof. Nicholas van As PACE trials and SBRT for prostate cancer
-
-
Mashup Score: 123Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial - 3 month(s) ago
PURPOSETo assess the efficacy and safety of radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) in treating recurrent small hepatocellular carcinoma (HCC).METHODSIn this trial, patients with recurrent small HCC (single lesion ≤5 cm) …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
Randomized comparison of SBRT vs RFA for recurrent small HCC (n=166 pts) - Freedom from local progression significantly improved after SBRT: 2a 92.7% vs 75.8%, HR=0.45 ! - No difference in PFS (median 37.6 vs 27.6mo) and OS (2a 97.6% vs 93.9%) https://t.co/Py9SBXYnU2
-
-
Mashup Score: 136Radiation Myelitis After Hypofractionated Spine Stereotactic Body Radiation Therapy - 3 month(s) ago
This cohort study characterizes the risk of radiation myelitis after spine stereotactic body radiation therapy to update the current dosimetric constraints.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Safe practice of spine SBRT requires high-quality data about SC dose tolerance - Cohort study 2051 pts - 30 cases of RM, 19 of which G3 to G4 - 2a rate of G1-4 RM 1.8% - cord dose D0.1cc of 19.1Gy / Dmax of 20.8Gy = 1.0% risk of G3 to G4 RM at 2 years https://t.co/tknB9jMRGb https://t.co/tHjRTWPcBM
-
-
Mashup Score: 37
To report final results of a prospective study of stereotactic body radiotherapy (SBRT) in patients with previously untreated solitary primary hepatocellular carcinoma (HCC).
Source: www.redjournal.orgCategories: General Medicine News, Oncologists1Tweet-
And yet another prospective trial confirming excellent efficacy of SBRT for localized HCC - n=36 pts - median tumor size 2.3 cm - median FU 49 mo - 3-year local control rate 93% - Grade 3 AE 11% https://t.co/RZKMzxNQyG https://t.co/cutqSGxuG5
-
-
Mashup Score: 119Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial - 3 month(s) ago
PURPOSETo assess the efficacy and safety of radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) in treating recurrent small hepatocellular carcinoma (HCC).METHODSIn this trial, patients with recurrent small HCC (single lesion ≤5 cm) …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
Randomized comparison of SBRT vs RFA for recurrent small HCC (n=166 pts) - Freedom from local progression significantly improved after SBRT: 2a 92.7% vs 75.8%, HR=0.45 ! - No difference in PFS (median 37.6 vs 27.6mo) and OS (2a 97.6% vs 93.9%) https://t.co/Py9SBXYnU2
-
‼️ TOMORROW - the very first ‼️ Virtual Grand Rounds in Radiation Oncology https://t.co/fIgYIx5hy7 17:00 - 17.30 CEST - Zoom link on Meeting homepage Prof. Nicholas van As PACE trials and SBRT for prostate cancer